scholarly journals Proportion of doctors who stayed in the state of Tocantins after finishing medical residency: preliminary results from a cross-sectional study

2018 ◽  
Vol 136 (1) ◽  
pp. 59-63 ◽  
Author(s):  
Leonardo Baldaçara ◽  
Raquel Prudente de Carvalho Baldaçara
2017 ◽  
Vol 15 (1) ◽  
pp. 85-91 ◽  
Author(s):  
Renato Mitsunori Nisihara ◽  
Ana Carolina Possebom ◽  
Luiza de Martino Cruvinel Borges ◽  
Ana Claudia Athanasio Shwetz ◽  
Fernanda Francis Benevides Bettes

ABSTRACT Objective To describe the profile of lawsuits related to drug requests filled at the Federal Justice of the State of Paraná. Methods A cross-sectional study, and the data were obtained through consulting the lawsuits at the online system of the Federal Justice of Paraná. Results Out of 347 lawsuits included in the study, 55% of plaintiffs were women, with a median age of 56 years. Oncology was the field with more requests (23.6%), and the highest mean costs. A wide variety of diseases and broad variety of requested drugs were found in the lawsuits. Approximately two-thirds of them were requested by the brand name, and the most often requested drugs were palivizumab and tiotropium bromide. Only 14.5% of the requested medicines were registered in the National Medication Register. The Public Defender’s Office filled actions in 89.6% of cases and all lawsuits had an interim relief. The mean time for approval was 35 days and 70% of requests were granted. Conclusion Oncology was the field with the highest demand for medicines at the Federal Justice of Paraná in 2014. A great variety of medications was requested. The Public Defender´s Office represented most lawsuits. All demands had an interim relief, and the majority of requests were granted, within an average of 35 days.


2020 ◽  
Vol 33 (1) ◽  
pp. e100149
Author(s):  
Caroline Elizabeth Sherry ◽  
Jonathan Z Pollard ◽  
Daniel Tritz ◽  
Branden K Carr ◽  
Aaron Pierce ◽  
...  

BackgroundReproducibility is a cornerstone of scientific advancement; however, many published works may lack the core components needed for study reproducibility.AimsIn this study, we evaluate the state of transparency and reproducibility in the field of psychiatry using specific indicators as proxies for these practices.MethodsAn increasing number of publications have investigated indicators of reproducibility, including research by Harwicke et al, from which we based the methodology for our observational, cross-sectional study. From a random 5-year sample of 300 publications in PubMed-indexed psychiatry journals, two researchers extracted data in a duplicate, blinded fashion using a piloted Google form. The publications were examined for indicators of reproducibility and transparency, which included availability of: materials, data, protocol, analysis script, open-access, conflict of interest, funding and online preregistration.ResultsThis study ultimately evaluated 296 randomly-selected publications with a 3.20 median impact factor. Only 107 were available online. Most primary authors originated from USA, UK and the Netherlands. The top three publication types were cohort studies, surveys and clinical trials. Regarding indicators of reproducibility, 17 publications gave access to necessary materials, four provided in-depth protocol and one contained raw data required to reproduce the outcomes. One publication offered its analysis script on request; four provided a protocol availability statement. Only 107 publications were publicly available: 13 were registered in online repositories and four, ten and eight publications included their hypothesis, methods and analysis, respectively. Conflict of interest was addressed by 177 and reported by 31 publications. Of 185 publications with a funding statement, 153 publications were funded and 32 were unfunded.ConclusionsCurrently, Psychiatry research has significant potential to improve adherence to reproducibility and transparency practices. Thus, this study presents a reference point for the state of reproducibility and transparency in Psychiatry literature. Future assessments are recommended to evaluate and encourage progress.


PLoS ONE ◽  
2012 ◽  
Vol 7 (1) ◽  
pp. e30627 ◽  
Author(s):  
Karine Baumstarck ◽  
Jean Pelletier ◽  
Valérie Aghababian ◽  
Françoise Reuter ◽  
Irina Klemina ◽  
...  

2020 ◽  
Vol 53 (1) ◽  
Author(s):  
Fernando Antônio Moreira Petri ◽  
Karina Sonalio ◽  
Henrique Meiroz de Souza Almeida ◽  
Marina Lopes Mechler-Dreibi ◽  
José Vanderlei Burim Galdeano ◽  
...  

2017 ◽  
Vol 135 (6) ◽  
pp. 511-517
Author(s):  
Walter Fernandes Azevedo ◽  
Lígia Andrade da Silva Telles Mathias

2016 ◽  
Vol 34 (7_suppl) ◽  
pp. 42-42 ◽  
Author(s):  
Pannaga G. Malalur ◽  
Manas Agastya ◽  
Yaser Dawod ◽  
Linha Phan ◽  
Mohammad talha Farooqui ◽  
...  

42 Background: The prevalence of depressive disorders in patients with malignancies is estimated at 20-50%, significantly greater than the general population. Existing literature reports a negative impact of depression on both the patient and their families. There is limited information regarding the impact of healthcare coverage on the prevalence of depression in such patients both in the state of Nevada and nationwide. Methods: A retrospective cross-sectional study was performed using the Behavioral Risk Surveillance System (BRFSS) database from 2010 to 2014. All adult subjects with a history of malignancy were included. Demographic factors and health care coverage were reviewed. Individuals with skin cancer as well as those with missing data were excluded. Patients were assigned to two groups based on their insurance coverage status. Study population was further stratified into Nevada and non-Nevada residents and analyzed. Association between depression and health care coverage across the study groups were assessed using Pearson chi-square test and regression models. Results: 183,530 subjects nationwide met our inclusion criteria. The Nevada population represented 1% (1676) of the total study sample. In Nevada, the prevalence of cancer patients without healthcare coverage was 7.5% (N = 126) compared to individuals with coverage 92% (N = 1550). This is significantly higher when compared to the national average of 4.9 % without coverage (p = 0.001). Overall, the rate of depression in cancer patients with no healthcare coverage nationally was notably higher compared to those with coverage (37.5% vs 22.7%, p = 0.001). Similarly, statistically higher rates of depression were noted in non-insured Nevada patients compared to those insured [49 (38.8%) vs. 357 (23%), p 0.001)]. Conclusions: This study demonstrates significant association between depression and lack of insurance coverage; both nationwide as well as in the state of Nevada. The proportion of uninsured Nevada residents with malignancies were higher compared to the national average. Improved and early screening for depression is crucial in mitigating the potential complications and morbidity associated with depression in patients with cancer.


2016 ◽  
Vol 49 (1) ◽  
pp. 25-30 ◽  
Author(s):  
Henrique Meiroz de Souza Almeida ◽  
Gabriel Yuri Storino ◽  
Daniele Araújo Pereira ◽  
Igor Renan Honorato Gatto ◽  
Luis Antonio Mathias ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document